Nina Lah from Lek among nominees for the title Female Engineer of the Year
- The project Female Engineer of the Year aims to improve the visibility of female engineers in society and enhance a broad and effective promotion of this profession among young women.
- Among ten nominees for the title Female Engineer 2019 was also Nina Lah, doctor of chemistry and head of the laboratory for particle analysis at Lek. Last year, a short-listed nominee for this title was Janja Žagar, Technical transfer Lead at Lek.
- With their nominations for the Female Engineer of the Year, Lek’s associates took on the role of ambassadors of the project that contributes to increasing the number of female engineers in society.
Today’s ceremony at Cankarjev Dom in Ljubljana marked the conclusion of the project to select the Female Engineer 2019, with which the organisers aim to improve the visibility of female engineers in society and increase interest in engineering careers among women. The selection process does not focus on the engineering achievements of individual women, but their potential to act as a role model and inspire upcoming generations of young women. The title Female Engineer 2019 went to Aida Kamišalić Latifić from the Faculty of Electrical Engineering and Computer Science, Maribor University. Among the ten nominees for this title was also Nina Lah, Head of the Particle Analysis Laboratory at Lek, which is part of Novartis.
»I am proud that I have been nominated together with a group of such exceptional female engineers and women. I believe that all of the nominees should be recognised as Female Engineers of the Year as should be also all other female engineers across Slovenia who are not exposed to media coverage. Such initiatives are an excellent opportunity to bring the engineering profession in all its shapes and forms to the general public and younger generation of women who are still in the process of making a decision about which career path to take. It is important to provide them with sufficient information about the opportunities offered by engineering profession and the diverse paths they can take on their journey to their goal,« stressed Nina Lah, who further upgraded her university degree in chemistry with a doctorate in this field, on this occasion. Nina joined Lek in 2015, after a ten-and-a half-year long journey in academia. Her laboratory work involves providing safe products for patients while at the same time, her knowledge and information also enable a faster production process.
This year, the title Female Engineer of the Year was awarded for the second time. In both selections, two female engineers from Lek were among the short-listed nominees. With this recognition they have become ambassadors of the project, contributing with their work and activities towards the goal of increasing the number of female engineers in society.
Novartis is the leading provider of medicines in Slovenia, where Lek, Novartis Pharma Services and Sandoz, operate. Together we are building and maintaining the reputation of a dynamic, ethical, and trusted pharmaceutical company. Lek develops, manufactures, and markets effective, safe, and high quality medicines and active pharmaceutical ingredients. With our knowledge, quality, and experience we have gained an important role in Novartis' organizational structure, especially in the Novartis Technical Operations, Global Drug Development, Novartis Business Services, and the generic division Sandoz. We are the leading Sandoz development center, and one of the key development sites for technologically complex projects. We invest a great deal in the development, education, and training of our employees. Over the last seven years, the company has created more than 2,250 jobs, making us one of the biggest employers in Slovenia. Novartis invested in Slovenia more than EUR 2.3 billion since 2003.
About Sandoz
Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access to healthcare by developing and commercializing novel, affordable approaches that address unmet medical need. Our broad portfolio of high-quality medicines, covering all major therapeutic areas and increasingly focused on value-adding differentiated medicines, accounted for 2018 sales of USD 9.9 billion. Sandoz is headquartered in Holzkirchen, in Germany’s Greater Munich area.
Sandoz is on Twitter. Sign up to follow @SandozGlobal at http://twitter.com/Sandoz_Global.
About Novartis
Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 108 thousand people of more than 140 nationalities work at Novartis around the world. Find out more at www.novartis.com.
This press release contains statements and conclusions based on projections of Lek’s future business operations. These estimates are derived from the best information currently available. In case these forecasts prove unreliable, the actual results could prove different from those projected.
For additional information contact:
Katarina Klemenc
Corporate Communications
Lek Pharmaceuticals d. d.
Phone: +386 1 580 22 43
katarina.klemenc@sandoz.com
